T2DM is associated with long-term chronic low-grade inflammation characterized by an increase in some inflammatory markers, such as TNF-α, IL-6, and CRP, contributing to insulin resistance and the pathogenesis of T2DM (Coope et al., 2016; Eguchi and Nagai, 2017). This evidence concerns the gene IL6 and type 2 diabetes mellitus.